Cargando…
MicroRNA-125b promotes tumor metastasis through targeting tumor protein 53-induced nuclear protein 1 in patients with non-small-cell lung cancer
BACKGROUND: Lung cancer, predominantly non-small-cell lung cancer (NSCLC), is the leading cause of cancer deaths worldwide. There is a great need to identify critical effectors involved in metastasis of NSCLC that will facilitate the development of new therapeutic strategies. Here we evaluated the p...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573481/ https://www.ncbi.nlm.nih.gov/pubmed/26388699 http://dx.doi.org/10.1186/s12935-015-0233-x |
_version_ | 1782390489615433728 |
---|---|
author | Li, Qinchuan Han, Yang Wang, Chunhong Shan, Shan Wang, Yuanyuan Zhang, Jingang Ren, Tao |
author_facet | Li, Qinchuan Han, Yang Wang, Chunhong Shan, Shan Wang, Yuanyuan Zhang, Jingang Ren, Tao |
author_sort | Li, Qinchuan |
collection | PubMed |
description | BACKGROUND: Lung cancer, predominantly non-small-cell lung cancer (NSCLC), is the leading cause of cancer deaths worldwide. There is a great need to identify critical effectors involved in metastasis of NSCLC that will facilitate the development of new therapeutic strategies. Here we evaluated the potential role of miR-125b in the metastasis of NSCLC cells. METHODS: Human NSCLC cells were isolated from surgical tissues with Cancer Cell Isolation Kit. Expressions of miR-125b and TP53INP1 were detected with real-time PCR and western blot. Human miR-125b mimics, miR-125b inhibitor, TP53INP1 expression plasmid and TP53INP1 siRNA were transfected into NSCLC cells with nucleofector transfection kit. NSCLC metastasis was determined with adhesion assay, invasive assay and lung tumor metastasis model. RESULTS: The expression of miR-125b was significantly higher in poorly differentiated NSCLC cells that are endowed with high metastatic potentials. Up-regulation of miR-125b could enhance the metastatic potential of NSCLC cells in vitro and in vivo, while down-regulation of miR-125b resulted in decreased metastatic potentials in vitro and in vivo. Further, tumor protein 53-induced nuclear protein 1 (TP53INP1) was an important target of miR-125b involved in metastasis of NSCLC cells. TP53INP1 served as a negative regulator of NSCLC metastasis. Decreased expression of TP53INP1 in tumor tissues was inversely associated with their expression of miR-125b, significantly lower in poorly differentiated tumors and inversely correlated with the clinical stages in patients with NSCLC. CONCLUSIONS: These findings demonstrated that miR-125b promoted tumor metastasis via targeting TP53INP1 in human NSCLC cells, which uncovered a real clinical relevance of microRNAs in tumor biology, and provided novel potential candidates for NSCLC clinical practice. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12935-015-0233-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4573481 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45734812015-09-19 MicroRNA-125b promotes tumor metastasis through targeting tumor protein 53-induced nuclear protein 1 in patients with non-small-cell lung cancer Li, Qinchuan Han, Yang Wang, Chunhong Shan, Shan Wang, Yuanyuan Zhang, Jingang Ren, Tao Cancer Cell Int Primary Research BACKGROUND: Lung cancer, predominantly non-small-cell lung cancer (NSCLC), is the leading cause of cancer deaths worldwide. There is a great need to identify critical effectors involved in metastasis of NSCLC that will facilitate the development of new therapeutic strategies. Here we evaluated the potential role of miR-125b in the metastasis of NSCLC cells. METHODS: Human NSCLC cells were isolated from surgical tissues with Cancer Cell Isolation Kit. Expressions of miR-125b and TP53INP1 were detected with real-time PCR and western blot. Human miR-125b mimics, miR-125b inhibitor, TP53INP1 expression plasmid and TP53INP1 siRNA were transfected into NSCLC cells with nucleofector transfection kit. NSCLC metastasis was determined with adhesion assay, invasive assay and lung tumor metastasis model. RESULTS: The expression of miR-125b was significantly higher in poorly differentiated NSCLC cells that are endowed with high metastatic potentials. Up-regulation of miR-125b could enhance the metastatic potential of NSCLC cells in vitro and in vivo, while down-regulation of miR-125b resulted in decreased metastatic potentials in vitro and in vivo. Further, tumor protein 53-induced nuclear protein 1 (TP53INP1) was an important target of miR-125b involved in metastasis of NSCLC cells. TP53INP1 served as a negative regulator of NSCLC metastasis. Decreased expression of TP53INP1 in tumor tissues was inversely associated with their expression of miR-125b, significantly lower in poorly differentiated tumors and inversely correlated with the clinical stages in patients with NSCLC. CONCLUSIONS: These findings demonstrated that miR-125b promoted tumor metastasis via targeting TP53INP1 in human NSCLC cells, which uncovered a real clinical relevance of microRNAs in tumor biology, and provided novel potential candidates for NSCLC clinical practice. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12935-015-0233-x) contains supplementary material, which is available to authorized users. BioMed Central 2015-09-17 /pmc/articles/PMC4573481/ /pubmed/26388699 http://dx.doi.org/10.1186/s12935-015-0233-x Text en © Li et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Primary Research Li, Qinchuan Han, Yang Wang, Chunhong Shan, Shan Wang, Yuanyuan Zhang, Jingang Ren, Tao MicroRNA-125b promotes tumor metastasis through targeting tumor protein 53-induced nuclear protein 1 in patients with non-small-cell lung cancer |
title | MicroRNA-125b promotes tumor metastasis through targeting tumor protein 53-induced nuclear protein 1 in patients with non-small-cell lung cancer |
title_full | MicroRNA-125b promotes tumor metastasis through targeting tumor protein 53-induced nuclear protein 1 in patients with non-small-cell lung cancer |
title_fullStr | MicroRNA-125b promotes tumor metastasis through targeting tumor protein 53-induced nuclear protein 1 in patients with non-small-cell lung cancer |
title_full_unstemmed | MicroRNA-125b promotes tumor metastasis through targeting tumor protein 53-induced nuclear protein 1 in patients with non-small-cell lung cancer |
title_short | MicroRNA-125b promotes tumor metastasis through targeting tumor protein 53-induced nuclear protein 1 in patients with non-small-cell lung cancer |
title_sort | microrna-125b promotes tumor metastasis through targeting tumor protein 53-induced nuclear protein 1 in patients with non-small-cell lung cancer |
topic | Primary Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573481/ https://www.ncbi.nlm.nih.gov/pubmed/26388699 http://dx.doi.org/10.1186/s12935-015-0233-x |
work_keys_str_mv | AT liqinchuan microrna125bpromotestumormetastasisthroughtargetingtumorprotein53inducednuclearprotein1inpatientswithnonsmallcelllungcancer AT hanyang microrna125bpromotestumormetastasisthroughtargetingtumorprotein53inducednuclearprotein1inpatientswithnonsmallcelllungcancer AT wangchunhong microrna125bpromotestumormetastasisthroughtargetingtumorprotein53inducednuclearprotein1inpatientswithnonsmallcelllungcancer AT shanshan microrna125bpromotestumormetastasisthroughtargetingtumorprotein53inducednuclearprotein1inpatientswithnonsmallcelllungcancer AT wangyuanyuan microrna125bpromotestumormetastasisthroughtargetingtumorprotein53inducednuclearprotein1inpatientswithnonsmallcelllungcancer AT zhangjingang microrna125bpromotestumormetastasisthroughtargetingtumorprotein53inducednuclearprotein1inpatientswithnonsmallcelllungcancer AT rentao microrna125bpromotestumormetastasisthroughtargetingtumorprotein53inducednuclearprotein1inpatientswithnonsmallcelllungcancer |